Lundbeck España S.A.

Av. Diagonal, 605, 9-1a
08028 Barcelona
Spain

Phone

lundbeck.es

About Lundbeck

Product portfolio of Lundbeck

Product portfolio

Show all

Microplate reading, made easy: flexible multi-mode microplate reader with simplified assay setup

Streamlined Single-Use TFF Platform for Process Development Through Pilot Manufacturing

Industry-optimized ERP for the life sciences industry

News about Lundbeck

14-Feb-2012 | research and development

Genmab Reaches Second Milestone in Lundbeck Collaboration

€1 million milestone payment to Genmab

Read news

19-Dec-2011 | business & finance

Genmab announces progress with Lundbeck collaboration

First pre-clinical milestone met in Lundbeck collaboration

Read news

04-Oct-2011 | business & finance

Lundbeck and Proximagen Sign Strategic Partnership Agreement

H. Lundbeck A/S and Proximagen Group plc

Read news

09-Sep-2011 | people

Marie-Laure Pochon elected as Lundbeck's new EVP of Commercial Operations

Lundbeck's Executive Management Group reduced from six to four members

Read news

17-Jun-2011 | research and development

Lundbeck: Nalmefene completes clinical phase III programme

Submission of the European Marketing Authorization Application (MAA) is expected by the end of 2011

Read news

17-May-2011 | research and development

H. Lundbeck starts clinical phase III study with Lu AA21004 in Japan

H. Lundbeck A/S and Takeda Pharmaceutical Company Limited announced the initiation of a phase III clinical trial in Japan for Lu AA21004 in patients with ...

Read news

09-Mar-2011 | research and development

FDA accepts Lundbeck's submission of the New Drug Application for clobazam

H. Lundbeck A/S announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for the investigational ...

Read news

10-Feb-2011 | business & finance

Lundbeck expands its commercial opportunities in Canada and Latin America

H. Lundbeck A/S announced that Lundbeck has been granted commercial rights to several Cephalon products in Canada and Latin America. As part of the ...

Read news

28-Jan-2011 | business & finance

Lundbeck Research USA, Inc. and BioFocus sign compound management agreement

BioFocus announced that its Compound Focus, Inc. subsidiary has signed a three-year compound management services agreement with Lundbeck Research USA, Inc ...

Read news

04-Jan-2011 | research and development

Biotie Announces Positive Results from First Two Phase III Studies with Nalmefene in Alcohol Dependence

Biotie's partner, H. Lundbeck A/S, has announced that it has completed two Phase III clinical trials evaluating nalmefene for the treatment of alcohol ...

Read news

22-Dec-2010 | business & finance

Lundbeck enters into drug discovery collaboration with Zenobia and Vernalis

H. Lundbeck A/S announced that it has signed agreements with Zenobia Therapeutics (Zenobia) and Vernalis plc (Vernalis) which will provide Lundbeck with ...

Read news

08-Dec-2010 | research and development

Lundbeck reports positive phase III study results for clobazam in the adjunctive treatment of seizures

H. Lundbeck A/S presented positive data from its pivotal phase III study to determine the efficacy and safety profiles of the investigational compound ...

Read news

15-Oct-2010 | business & finance

Genmab Announces Antibody Development Collaboration with Lundbeck

Genmab A/S announced an agreement to create and develop human antibody therapeutics for disorders of the central nervous system (CNS) with H. Lundbeck A/S ...

Read news

14-Oct-2010 | business & finance

Lundbeck and Merck sign exclusive commercialisation agreement for SYCREST (asenapine) sublingual tablets

Lundbeck expects to launch SYCREST in the EU at the beginning of 2011

Read news

07-Oct-2010 | business & finance

Lundbeck enters into license agreement with Kyowa Hakko Kirin for A2a antagonists for Parkinson's and other indications

H. Lundbeck A/S announced that it has signed an agreement with Kyowa Hakko Kirin Co., Ltd. providing Lundbeck with exclusive rights to develop and ...

Read news

Show more news about Lundbeck

Gentle Counterflow Centrifugation for Superior Cell Processing Results